FibroGen, Inc (FGEN) insider have most recently took part in a trading activity. On Dec 4, 2017 Lema Gerald, Director bought 3,500 shares having total worth of $163,450 at the price of $46.7 per share, following the transaction a total of 3,500 shares owned by Lema Gerald.
The stock has experienced a total of 14 insider trades in the past three months. These trades include 14 sell activities .Furthermore, over the past 12 months , the stock was traded 63 times by insiders. In 63 of these trades, the insider was a seller .
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of FibroGen, Inc (FGEN) traded down 5.62% on Dec 4, 2017, hitting $44.5. 451,259 shares of the company’s stock traded hands. FibroGen, Inc has a 52 week low of $14.85 and a 52 week high of $60.1. The company’s market cap is $1,410 million.
FibroGen, Inc (FGEN) last announced its earnings results on Nov 8, 2017. The company reported -0.50 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.37 by $0.13. The company had revenue of $27 million for the quarter, compared to the consensus estimate of $40 million. During the same quarter in the previous year, the company posted -0.38 earnings per share. The company’s revenue for the quarter was down 9% on a year-over-year basis.
|earnings per share||-0.50||-0.48||-0.52||-0.50||-0.38||0.35||-0.45||-0.86||-0.74||0.83|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018